Similar articles for PMID: 19351765

Year	Number of Results
1987	1
1988	1
1989	1
1991	1
1994	1
1995	2
1996	3
1997	5
1998	3
1999	2
2000	5
2001	4
2002	9
2003	9
2004	5
2005	2
2006	6
2007	4
2008	6
2009	5
2010	4
2011	5
2012	7
2013	4
2014	4
2015	5
2016	2
2017	2
2018	3
2019	1
2020	1
2021	1
2024	0

1

A phase I study of a combination of yttrium-90-labeled anti-carcinoembryonic antigen (CEA) antibody and gemcitabine in patients with CEA-producing advanced malignancies.

Shibata S, Raubitschek A, Leong L, Koczywas M, Williams L, Zhan J, Wong JY. Shibata S, et al. Clin Cancer Res. 2009 Apr 15;15(8):2935-41. doi: 10.1158/1078-0432.CCR-08-2213. Epub 2009 Apr 7. Clin Cancer Res. 2009. PMID: 19351765 Free PMC article. Clinical Trial.

2

A phase I radioimmunotherapy trial evaluating 90yttrium-labeled anti-carcinoembryonic antigen (CEA) chimeric T84.66 in patients with metastatic CEA-producing malignancies.

Wong JYC, Chu DZ, Yamauchi DM, Williams LE, Liu A, Wilczynski S, Wu AM, Shively JE, Doroshow JH, Raubitschek AA. Wong JYC, et al. Clin Cancer Res. 2000 Oct;6(10):3855-63. Clin Cancer Res. 2000. PMID: 11051230 Clinical Trial.

3

A phase I trial of (90)Y-DOTA-anti-CEA chimeric T84.66 (cT84.66) radioimmunotherapy in patients with metastatic CEA-producing malignancies.

Wong JY, Chu DZ, Williams LE, Liu A, Zhan J, Yamauchi DM, Wilczynski S, Wu AM, Yazaki PJ, Shively JE, Leong L, Raubitschek AA. Wong JY, et al. Cancer Biother Radiopharm. 2006 Apr;21(2):88-100. doi: 10.1089/cbr.2006.21.88. Cancer Biother Radiopharm. 2006. PMID: 16706629 Clinical Trial.

4

Dose escalation trial of indium-111-labeled anti-carcinoembryonic antigen chimeric monoclonal antibody (chimeric T84.66) in presurgical colorectal cancer patients.

Wong JY, Chu DZ, Yamauchi D, Odom-Maryon TL, Williams LE, Liu A, Esteban JM, Wu AM, Primus FJ, Beatty JD, Shively JE, Raubitschek AA. Wong JY, et al. J Nucl Med. 1998 Dec;39(12):2097-104. J Nucl Med. 1998. PMID: 9867150 Free article. Clinical Trial.

5

A Phase I trial of 90Y-anti-carcinoembryonic antigen chimeric T84.66 radioimmunotherapy with 5-fluorouracil in patients with metastatic colorectal cancer.

Wong JY, Shibata S, Williams LE, Kwok CS, Liu A, Chu DZ, Yamauchi DM, Wilczynski S, Ikle DN, Wu AM, Yazaki PJ, Shively JE, Doroshow JH, Raubitschek AA. Wong JY, et al. Clin Cancer Res. 2003 Dec 1;9(16 Pt 1):5842-52. Clin Cancer Res. 2003. PMID: 14676105 Review.

6

Phase I/II Trial of Anticarcinoembryonic Antigen Radioimmunotherapy, Gemcitabine, and Hepatic Arterial Infusion of Fluorodeoxyuridine Postresection of Liver Metastasis for Colorectal Carcinoma.

Cahan B, Leong L, Wagman L, Yamauchi D, Shibata S, Wilzcynski S, Williams LE, Yazaki P, Colcher D, Frankel P, Wu A, Raubitschek A, Shively J, Wong JYC. Cahan B, et al. Cancer Biother Radiopharm. 2017 Sep;32(7):258-265. doi: 10.1089/cbr.2017.2223. Cancer Biother Radiopharm. 2017. PMID: 28910150 Free PMC article. Clinical Trial.

7

Initial experience evaluating 90yttrium-radiolabeled anti-carcinoembryonic antigen chimeric T84.66 in a phase I radioimmunotherapy trial.

Wong JY, Williams LE, Yamauchi DM, Odom-Maryon T, Esteban JM, Neumaier M, Wu AM, Johnson DK, Primus FJ, Shively JE, et al. Wong JY, et al. Cancer Res. 1995 Dec 1;55(23 Suppl):5929s-5934s. Cancer Res. 1995. PMID: 7493373 Clinical Trial.

8

Clinical evaluation of indium-111-labeled chimeric anti-CEA monoclonal antibody.

Wong JY, Thomas GE, Yamauchi D, Williams LE, Odom-Maryon TL, Liu A, Esteban JM, Neumaier M, Dresse S, Wu AM, Primus FJ, Shively JE, Raubitschek AA. Wong JY, et al. J Nucl Med. 1997 Dec;38(12):1951-9. J Nucl Med. 1997. PMID: 9430476 Free article. Clinical Trial.

9

Phase I Study of Yttrium-90 Radiolabeled M5A Anti-Carcinoembryonic Antigen Humanized Antibody in Patients with Advanced Carcinoembryonic Antigen Producing Malignancies.

Akhavan D, Yazaki P, Yamauchi D, Simpson J, Frankel PH, Bading J, Colcher D, Poku K, Chen YJ, Lim D, Cristea M, Wu A, Shively J, Wong JYC. Akhavan D, et al. Cancer Biother Radiopharm. 2020 Feb;35(1):10-15. doi: 10.1089/cbr.2019.2992. Epub 2020 Jan 7. Cancer Biother Radiopharm. 2020. PMID: 31910346 Free PMC article. Clinical Trial.

10

Initial clinical experience evaluating Yttrium-90-chimeric T84.66 anticarcinoembryonic antigen antibody and autologous hematopoietic stem cell support in patients with carcinoembryonic antigen-producing metastatic breast cancer.

Wong JY, Somlo G, Odom-Maryon T, Williams LE, Liu A, Yamauchi D, Wu AM, Yazaki P, Wilczynski S, Shively JE, Forman S, Doroshow JH, Raubitschek AA. Wong JY, et al. Clin Cancer Res. 1999 Oct;5(10 Suppl):3224s-3231s. Clin Cancer Res. 1999. PMID: 10541368 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

101 results

Results by year